IRCM - Institut de Recherche en Cancérologie de Montpellier Revenue and Competitors

Montpellier, USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • IRCM - Institut de Recherche en Cancérologie de Montpellier's estimated annual revenue is currently $13.9M per year.(i)
  • IRCM - Institut de Recherche en Cancérologie de Montpellier's estimated revenue per employee is $102,000

Employee Data

  • IRCM - Institut de Recherche en Cancérologie de Montpellier has 136 Employees.(i)
  • IRCM - Institut de Recherche en Cancérologie de Montpellier grew their employee count by 9% last year.

IRCM - Institut de Recherche en Cancérologie de Montpellier's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13M12743%N/AN/A
#2
$11.2M11062%N/AN/A
#3
$27.3M24310%N/AN/A
#4
$26M23725%$11MN/A
#5
$3.3M41-11%N/AN/A
#6
$11.6M11424%N/AN/A
#7
$1.6M225%N/AN/A
#8
$5.9M6410%N/AN/A
#9
$27.8M24828%N/AN/A
#10
$3.7M45-56%N/AN/A
Add Company

What Is IRCM - Institut de Recherche en Cancérologie de Montpellier?

The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier and Institut du Cancer de Montpellier (CLCC) 220 scientists and support personnel 17 research teams sharing 5000 m2 of lab space Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus Biotech spin-offs Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM One central theme and two unifying programs : Molecular Targets and Cancer Therapy 1. Plasticity of solid tumors : from discoveries to personalized medecine 2. Therapeutic Antibodies in Cancer Treatment : Innovation, design and biological response

keywords:N/A

N/A

Total Funding

136

Number of Employees

$13.9M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.7M1360%N/A
#2
$25.3M14450%N/A
#3
$32.9M14635%N/A
#4
$28.1M14712%N/A
#5
$34.9M15142%N/A